AI-Media et Speechmatics annoncent un partenariat stratégique pour faire évoluer les technologies de sous-titrage et de services linguistiques

BROOKLYN, New York, 13 sept. 2024 (GLOBE NEWSWIRE) — AI-Media, leader mondial de la technologie d’encodage audiovisuel et des solutions de transcription et de traduction pilotées par l’IA, et Speechmatics, leader du marché de la technologie de reconnaissance automatique de la parole, annoncent, ce jour, une expansion stratégique de leur partenariat pluriannuel afin de commercialiser […]

Wilbur Watch Co. Named 2024 American Watch Brand of the Year

WILBUR LEO WATCH NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) — Wilbur Watch Co. is proud to announce that it has been voted the 2024 American Watch Brand of the Year at the prestigious WatchPro Awards in New York City. This esteemed award recognizes the innovative craftsmanship, forward-thinking design, and unparalleled commitment to excellence that Wilbur Watch Co. has […]

Bitget a acquis 1,7 million d’utilisateurs en août, selon le dernier rapport mensuel

VICTORIA, Seychelles, 12 sept. 2024 (GLOBE NEWSWIRE) — Bitget, la principale bourse de crypto-monnaie et société Web3, a communiqué son rapport d’août 2024 sur la transparence qui met en évidence une croissance significative avec l’acquisition de 1,72 million d’utilisateurs malgré des conditions de marché difficiles. Le marché des crypto-monnaies a connu de fortes baisses, le Bitcoin […]

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

AI-Media and Speechmatics Partnership BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. […]

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]